Alloxan糖尿病家兎の皮膚抵抗力減弱に関する実験的研究 by 板谷, 博之
TitleAlloxan糖尿病家兎の皮膚抵抗力減弱に関する実驗的研究
Author(s)板谷, 博之













EXPERIMENTAL STUDIES ON THE PRODUCTION OF THE 
OPSONINE IN THE SKIN OF THE ALLOXAN R.ABBIT 
by 
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From the 2nd Surgical Division, Kyoto University Medical schol 
(Director: Prof. Dr. Y ASUMASA AovAaI) 
SUMMARY 
Much discussion has been given to the problem that, at the time of diabetes 
mellitus, pyogeri.ic diseases such as furuncles, carbuncles, etc. tend to begin in the 
skin, and it lingers to recover, namely the problem of inviting a decreased resist-
ance to pyogenic bacteria. 
Hardly anything, however, has been clarified with respect to its cause. 
Since diabetes ・ mellitus presents the disfunction of carbohydrate metabolism 
as its main symptoms, the hyperglycemia has been always the center of this 
problem. 
B1:1t even with the hyperglycemia itself, some say it is harmful while others 
insist harmless, and no consistent opinion has been built up. In the recent years, 
it・ appears that the hyperglycemia has been considered less harmful. 
Our experiments have been carried out on the production of the opsonine in 
the skin of the alloxan rabbits, the results of which were as follows: 
I. When a hyperglycemia with its blood sugar value over 300mg/dl continued 
for more than 12 weeks, the opsonine value in the skin decreased below its 
normal value. 
2. Even when the blood sugar value was over 300 mg/dl, if it continued only 
for a shorter time, and when it was below 300 mg/ dl, no change was observed 
in the production of the opsonine even after continuing for 30 weeks. 
3. If insulin was injected to such rabbits whose opsonine value3 in the skin 
decreased, the opsonine values recovered one week after the blood suger value 
became below 300 mg/dl, and after another week it returned to the normal value. 
4. Even if glucose alone was injected to normal rabbits and their blood sugar 
values kept over 300 mg/dl, no change could be observed in the opsonine values 
in the skin. 
5. From the above stated, it can be concluded that a decreased resistance to 
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the pyogenic infection of the skin brought out at the time of diabetes mellitus 




















































































































ず， Dunn,Sheehan & McLethieは100～150mg/kg,
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図 2. Alloxan 180mg/kg静注時の皮内オ7・｝＇ ＝：.；値，血糖値及び血中残余罪素値の推移
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Ji!Pち， No.16 （図 l), No.き1（図2),No. 34 （図
3), No. 36’（図4), No. 39 （図5）の如く，糖尿病
発症後血糖停が300mg/dl以上の高値を維持した症例
では，全1:91に於てオプヅニン値の低下がみられた.j;p 
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図 7. Alloxan200mg/kg静注時の皮内オプソ＝γ値，血糖値及び血t(r残余蛍素値の推移 によって来る糖
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効待聞が6涛間前後である為， 1日数回の汐射を必要と 1&12. 20%葡萄糖注射lr.i＇の皮内オプソユン
















































図13. 7・ロタミ γ ・チシク・インシ A 1J Y3.5翠位注射時の で皮内オプヅエン値は漸次回復して
血糠値の変動 来る．而して，オプソユン値が正常
値に回復するには，それより更に
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,," :, －－－・ー －ー ーー ～『 て実験じた結果，次のようなF績を
,. ____ _, 得た．
1) 血糖値300mg/dl以主の混血糖
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